|
1AN1
LEECH-DERIVED TRYPTASE INHIBITOR/TRYPSIN COMPLEX
Deposited 1997-06-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain I
1–46(46 aa)
|
Mutation:N115D (D-ASPARTIC ACID FORM)
|
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;30% V/V 2-PROPANOL, 0.2M AMMONIUM ACETATE, 0.1M TRIS-HCL, PH 8.5 ROOM TEMPERATURE 27 MONTHS FOR GROWTH.
|
Resolution 2.03 Å
R-free 0.228
|
|
1LDT
COMPLEX OF LEECH-DERIVED TRYPTASE INHIBITOR WITH PORCINE TRYPSIN
Deposited 1997-05-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain L
1–46(46 aa)
|
Not recorded
|
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;10% PEG 6000, 2.3M PHOSPHATE, PH 8.0
|
Resolution 1.90 Å
|
|
2KMO
Solution structure of native Leech-derived tryptase inhibitor, LDTI
Deposited 2009-08-03
|
Parsed fields agree
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–44(44 aa)
Fragment:residues 1-44
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 1.7;298 K;Pressure ambient
NMR sample composition
1.7 mM LDTI, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
1.7 mM LDTI, 100% D2O | 100% D2O
|
Resolution not provided
|
|
2KMQ
Solution structure of intermediate IIb of Leech-derived tryptase inhibitor, LDTI.
Deposited 2009-08-03
|
Different experimental conditions
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–44(44 aa)
Fragment:residues 1-44
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 1.7;298 K;Pressure ambient
NMR sample composition
1.7 mM LDTI-IIb, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
1.7 mM LDTI-IIb, 100% D2O | 100% D2O
|
Resolution not provided
|
|
2KMR
Solution structure of intermediate IIc of Leech-derived tryptase inhibitor, LDTI.
Deposited 2009-08-03
|
Different experimental conditions
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–44(44 aa)
Fragment:residues 1-44
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 1.7;298 K;Pressure ambient
NMR sample composition
1.7 mM LDTI-IIc, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
1.7 mM LDTI-IIc, 100% D2O | 100% D2O
|
Resolution not provided
|